Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Jul 31, 2025 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 47.71%8.1B | 32.04%5.48B | 15.37%1.72B | 56.81%1.72B | 8.25%892.67M | 55.18%1.15B | 50.11%4.15B | 78.43%1.49B | 53.90%1.1B | 26.16%824.63M |
| Cost of revenue | 71.33%4.56B | 63.09%2.66B | 31.47%1B | 114.21%896.84M | 15.63%295.69M | 138.99%466.01M | 76.83%1.63B | 200.14%760.92M | 92.37%418.67M | 9.10%255.72M |
| Gross profit | 25.47%3.54B | 11.97%2.82B | -1.50%714.96M | 21.46%825.75M | 4.93%596.97M | 25.34%686.51M | 36.76%2.52B | 25.21%725.86M | 37.03%679.85M | 35.70%568.91M |
| Operating expense | 22.48%3.27B | 0.53%2.67B | 11.88%734.38M | -0.58%688.11M | -7.43%609.07M | -1.69%637.37M | 1.39%2.65B | -4.08%656.4M | 3.47%692.1M | -1.92%657.96M |
| Operating profit | 76.81%274.51M | 217.20%155.26M | -127.97%-19.43M | 1,224.15%137.64M | 86.42%-12.1M | 148.84%49.14M | 82.88%-132.47M | 166.40%69.46M | 92.91%-12.24M | 64.61%-89.06M |
| Net non-operating interest income (expenses) | -65.19%-47.4M | -134.70%-28.69M | -209.74%-7.73M | -359.80%-12.13M | -129.44%-5.05M | 22.52%-3.79M | 38.61%-12.23M | 61.46%-2.5M | 13.60%-2.64M | 2.39%-2.2M |
| Non-operating interest income | 2,662.22%1.24M | 181.25%45K | --0 | 333.33%26K | --0 | 111.11%19K | -36.00%16K | --1K | -57.14%6K | --0 |
| Non-operating interest expense | 113.57%48.64M | 148.29%22.78M | 209.62%7.73M | 160.61%6.89M | 185.63%5.05M | 37.25%3.11M | -6.53%9.17M | 22.17%2.5M | -13.80%2.64M | -21.60%1.77M |
| Total other finance cost | ---- | 94.30%5.96M | --0 | --5.26M | --0 | -73.44%700K | -69.69%3.07M | --0 | --0 | --433K |
| Net investment income | 0.00%2K | 2K | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -110.25%-5M | 48.77M | -2.01M | 0 | ||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -191.42%-33.64M | 571.33%36.79M | -91.47%-16.54M | 268.75%1.65M | 12,863.80%49.78M | 1.9M | 67.09%-7.81M | -2,217.16%-8.64M | 101.72%448K | 118.18%384K |
| Less:Restructuring and mergern&acquisition | --25.19M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | 114.75%8.45M | -1,414.92%-57.26M | -33.41%-3.93M | -268.75%-1.65M | ---49.78M | ---1.9M | -56.13%-3.78M | -622.55%-2.95M | -252.76%-448K | ---- |
| Less:Write off | --0 | 76.70%20.47M | ---- | ---- | ---- | ---- | -55.68%11.59M | --11.59M | ---- | ---- |
| Other non-operating income (expenses) | -119.37%-27.37M | -104.44%-12.48M | -39.67%-3.14M | -42.47%-4.57M | -566.31%-3.89M | 40.78%-877K | -162.11%-6.1M | -308.36%-2.25M | -334.24%-3.21M | 83.70%834K |
| Income before tax | -19.30%161.11M | 225.88%199.65M | -187.10%-48.84M | 794.82%122.59M | 188.33%79.53M | 143.34%46.37M | 80.66%-158.6M | 150.42%56.08M | 91.29%-17.64M | 64.45%-90.04M |
| Income tax | 440.26%54.47M | -331.34%-16.01M | -1,474.69%-19.88M | 13.43%1.29M | 13.09%1.29M | -59.65%1.29M | 176.91%6.92M | -26.90%1.45M | 550.86%1.14M | 561.63%1.14M |
| Net income | -50.55%106.64M | 230.29%215.66M | -153.01%-28.96M | 745.84%121.3M | 185.81%78.24M | 140.91%45.08M | 79.87%-165.52M | 148.26%54.63M | 90.74%-18.78M | 64.02%-91.18M |
| Net income continuous operations | -50.55%106.64M | 230.29%215.66M | -153.02%-28.96M | 745.81%121.3M | 185.81%78.24M | 140.91%45.08M | 79.87%-165.52M | 148.26%54.63M | 90.73%-18.78M | 64.02%-91.17M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -50.55%106.64M | 230.29%215.66M | -153.01%-28.96M | 745.84%121.3M | 185.81%78.24M | 140.91%45.08M | 79.87%-165.52M | 148.26%54.63M | 90.74%-18.78M | 64.02%-91.18M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -50.55%106.64M | 230.29%215.66M | -153.01%-28.96M | 745.84%121.3M | 185.81%78.24M | 140.91%45.08M | 79.87%-165.52M | 148.26%54.63M | 90.74%-18.78M | 64.02%-91.18M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -49.08%9.38 | 224.21%18.42 | -152.21%-2.72 | 679.67%10.55 | 181.35%6.76 | 138.65%3.83 | 80.06%-14.83 | 151.43%5.21 | 90.03%-1.82 | 63.76%-8.31 |
| Diluted earnings per share | -48.90%9.33 | 223.13%18.26 | -155.93%-2.72 | 675.27%10.47 | 180.87%6.72 | 138.14%3.78 | 80.06%-14.83 | 147.75%4.863 | 90.03%-1.82 | 63.76%-8.31 |
| Dividend per share | ||||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |